Friday, July 19, 2013

Study: H7N9 highly transmissible by airborne route

[bolding is mine]
Lisa Schnirring | Staff Writer | CIDRAP News

Jul 18, 2013
Chinese researchers who did extensive work on H7N9 viruses from birds and humans found that one of the human strains was highly transmissible by aerosol droplets in ferrets, fueling more concerns that the new virus could spread between people.
The potential for aerosol spread is one of the key factors health officials use in gauging a new virus's pandemic potential, and the new study follows closely on the heels of two others that also found evidence of respiratory droplet transmission in ferrets.
The newest findings were reported today in an early online edition of Science by a team based at the Harbin Veterinary Research Institute, a World Health Organization (WHO) collaborating center.

Genetic comparisons produce new clues

Scientists ran multiple tests on H7N9 viruses obtained during poultry surveillance and isolated from human cases to get a clearer picture of its pathogenicity, virulence, replication, and transmissibility.
They sequenced the genomes of 37 representative H7N9 samples, most of which came from live-poultry markets, and compared them with five human isolates. The hemagglutinin (HA) and neuraminidase (NA) genes were highly similar, but they found more diversity in the six internal genes. They also found that the viruses are still capable of frequent reassortment and rapid evolution.
When they examined the basic polymerase 2 (PB2) gene for amino acids associated with flu virulence and transmission in mammals, they found that all of the bird and environment samples had the amino acid combination 627E/701D. The human isolates, in contrast, had either the 627K or 701N mutation, both of which are important for virulence and transmission.
The group wrote that the findings suggest the mutations may have occurred during replication in humans.
Experiments to explore receptor binding, another factor that plays a role in flu virus replication and transmission, identified a 1243V mutation that—similar to the Q226L mutation—may play a key role in exclusive binding to humanlike receptors for two of the avian isolates and two of the human samples.

Tests track aerosol transmission, other factors

Virulence and infection tests in birds confirmed that the H7N9 virus was low pathogenic in poultry and that infected chickens shed the virus for up to 7 days.The researchers said this finding suggests that chickens "may be one of the major carriers and spreaders of H7N9 viruses in the live poultry markets."
In tests on mice that were given lethal doses of H7N9, no signs of disease or death were seen in the ones that received viruses isolated from birds, but the animals infected with human isolates lost weight, got very sick, or died. Similarly, the group's replication tests on mice infected with human strains found higher viral titers in the nasal passages and lungs when compared with animals infected by the bird strains.
Replication experiments in ferrets also showed differences between the bird and human H7N9 strains. The group's pathology tests on ferret lung samples found severe bronchopneumonia and prominent viral antigen expression in the animals infected with three human strains and one of the bird strains. Ferret lungs, though, appeared normal after infection with a poultry H7N9 strain.
Aerosol transmission studies involved placing uninfected ferrets in cages adjacent to those housing infected ferrets. The investigators found H7N9 in one ferret exposed to those infected with one of the bird strains and two human strains isolated from some of the first patients in Shanghai. However, the virus was detected in all three ferrets exposed to animals infected with a human H7N9 strain isolated form a patient in Anhui province (AH/1).
To assess reproducibility, they repeated the aerosol transmission test with the AH/1 isolate and got the same result.
Senior author Hualan Chen, PhD, told CIDRAP News that there was no significant difference in transmission among four of the five viruses they tested in aerosol transmission testing. "The transmission of AH/1 to all three ferrets suggests that the H7N9 virus has great pandemic potential," she said.
The team noted that it's difficult to pinpoint which amino acid substitution alone makes the virus highly transmissible, but the amino acid differences between the avian viruses and the Anhui virus range from 1 to 27, suggests that only a few changes are needed to make the virus highly transmissible in mammals.
"Moreover, these changes can occur easily during replication in humans," they added.
Overall, the team said their tests found that the H7N9 viruses from poultry and humans can bind to human airway receptors and can replicate efficiently in ferrets, and that one human isolate can transmit efficiently among ferrets by aerosol droplets.
Chen said she was surprised that all of the viruses tested are able to bind to humanlike receptors and that the PB2 gene of the virus so easily gains mutations during replication in humans that boost its virulence and transmissibility.

Experts weigh pandemic potential

She said the group's findings are useful for weighing the threat from the virus. "This study suggests that the H7N9 virus is likely to transmit in humans, and immediate action, not only in China, is needed to prevent a possible pandemic caused by such a virus," Chen said.
The ability of the virus to transmit easily in poultry across a large part of China over a brief period points to the importance of control measures in poultry markets, the group said. But stamping out H7N9 will be a big, long-term challenge, because the virus spreads silently in chickens and also spreads to humans.
Ian Mackay, PhD, a virologist at the Australian Infectious Diseases Research Centre at the University of Queensland, told CIDRAP News that the study's molecular epidemiology component is the largest of its kind to date and adds many more complete H7N9 genomes to the publicly accessible GenBank database.  Mackay also authors the Virology Down Under Web site.
He noted that the group's comparison between the human and avian strains found that they differed by less than 4% at the nucleotide level, "Sometimes there are no differences," he said, noting that the most divergent strains came from the Shanghai region, where 20% of the samples originated.
The team's infection experiments on chickens confirm that H7N9 is a silent spreader and that the birds shed the virus for about a week before their illness resolves, Mackay said.
Findings revealed that major differences between H7N9 viruses are at the amino acid level, with the most divergent segment at the PB1 gene. "But it is the PB2 and HA segment that harbors mutations of particular interest to document the journey from infrequent spillover events to sustained human-to-human pandemic-level transmission," he said.
Mackay added: "We know that pandemic potential does not rest solely on one or other amino acid change, but rather a collection of changes. We also don't know what we don't know yet."
The Harbin group showed the potential of H7N9 viruses to bind to both avian and human receptors and that human isolates replicated well in the upper airways, a site for efficient transmission, he noted.
"The study reinforces that even 'lowly' or inefficient transmission—only 33% of ferrets, for example—is still transmission," Mackay said. "That proportion would lead to a lot of human cases in densely populated or frequented areas."
Those factors might help explain the wide clinical spectrum that has been seen, as well as difficulties in tracking the source and the proportion of patients who get severely ill and die, he said.
Zhang Q, Shi J, Deng G, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 2013 Jun 18 [Abstract]
http://www.cidrap.umn.edu/news-perspective/2013/07/study-h7n9-highly-transmissible-airborne-route

#MERS #Coronavirus UAE - 2 HCW's w/mild upper respiratory sym's not hospitalized

By AFP | AFP – 16 hours ago
Excerpt:

In Saudi Arabia, one 42-year-old female health care worker and a 26-year-old man who were in close contact with a MERS patient are both suffering from mild symptoms and have not been hospitalised, WHO said.

http://en-maktoob.news.yahoo.com/six-more-cases-mers-virus-confirmed-191022044.html 

#MERS #Coronavirus United Arab Emirates Case List

This is my case list for the UAE.  The first case dates back to March, 2013.


Date Report:  3/26/13 – 17 Total Confirmed, 11 Deaths
Name:  73yo
From:  United Arab Emirates
Onset:  3/14
Adm:  3/19  Munich Klinikum Schwabing Hospital Flown from UAE
in private Jet,  on day 11 of illness
Confirmation:  3/23/13
DOD:  3/25/13
Note:  Died on day 18 of illness. 50 people being monitored medically.  Unchanged.
The full virus genome was combined with four other available full genome sequences in a maximum likelihood phylogeny, correlating branch lengths with dates of isolation. The time of the common ancestor was halfway through 2011. Addition of novel genome data from an unlinked case treated 6 months previously in Essen, Germany, showed a clustering of viruses derived from Qatar and the United Arab Emirates.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970154-3/abstract

Date of Report  7/12/13 – Blue Font Represents contact cluster
Name:  82(M) – Index Case
From:  United Arab Emirates
Adm:  Hospital in Abu Dhabi, ICU
Note:  Is hospitalized with multiple myeloma.  

Date of Report:  7/18/13
Name:  28(M)
From:  Abu Dhabi
Note:  Healthcare worker of confirmed 82(M) above.  No sym’s.  Identified thru surveillance of confirmed case (82M 7/12).  From one of two hospitals.
WHO Update: http://www.who.int/csr/don/2013_07_18/en/index.html

Name:  30(F)
From:  Abu Dhabi
Note:  Healthcare worker of confirmed 82(M) above.  No sym’s.  Identified thru surveillance of confirmed case (82M 7/12).  From one of two hospitals.
WHO Update: http://www.who.int/csr/don/2013_07_18/en/index.html

Name:  30(F)
From:  Abu Dhabi
Note:  Healthcare worker of confirmed 82(M) above.  Upper respiratory sym’s.  Identified thru surveillance of confirmed case (82M 7/12).  Worked at one of two hospitals.  Stable condition.
WHO Update: http://www.who.int/csr/don/2013_07_18/en/index.html

Name:  40(F)
From:  Abu Dhabi
Note:  Healthcare worker of confirmed 82(M) above.  Syms: upper respir.  Stable condition.  Identified thru surveillance of confirmed case (82M 7/12).  From one of two hospitals.
WHO Update: http://www.who.int/csr/don/2013_07_18/en/index.html



 

WHO Middle East respiratory syndrome coronavirus (MERS-CoV) - update 7/18/13

WHO has been informed of six additional laboratory-confirmed cases of infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Of these, two cases have been reported from Saudi Arabia and four from the United Arab Emirates (UAE).
Both the cases in Saudi Arabia have mild symptoms and are not hospitalized. They are from Asir region. The first case is a 26-year-old man who is a close contact with a previously laboratory-confirmed case and the second case is a 42-year-old woman who is a health care worker.
In the UAE, the four cases are health care workers from two hospitals in Abu Dhabi who took care of an earlier laboratory-confirmed patient. Of these, two cases, a 28-year-old man and 30-year-old woman, did not develop symptoms of illness. The other two cases, both women of 30 and 40 years old, had mild upper respiratory symptoms and are in stable condition.
Globally, from September 2012 to date, WHO has been informed of a total of 88 laboratory-confirmed cases of infection with MERS-CoV, including 45 deaths.
Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.
Health care providers are advised to maintain vigilance. Recent travelers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations.
Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that MERS-CoV infection should be considered even with atypical signs and symptoms, such as diarrhea, in patients who are immunocompromised.
Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.
All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.
WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.
WHO has convened an Emergency Committee under the International Health Regulations (IHR) to advise the Director-General on the status of the current situation. The Emergency Committee, which comprises international experts from all WHO Regions, unanimously advised that, with the information now available, and using a risk-assessment approach, the conditions for a Public Health Emergency of International Concern (PHEIC) have not at present been met.

http://www.who.int/csr/don/2013_07_18/en/index.html 

#MERS #Coronavirus UAE: 4 New Cases - all are contact cases of previous confirmed

The Health Authority Abu Dhabi (Haad) has registered four new cases with coronavirus. The new registered cases are in stable conditions.
It said: "As a preventive measure, they have been isolated to prevent transmission to others."
Immediately after discovering the first case, Haad in coordination with the Ministry of Health (MoH), started investigating and examining people with direct contact with the first patient.
The Haad noted that a total of 136 individuals representing medical staff and family members of the patient were examined. As a result of the screening, four new cases with the virus were confirmed.
The Ministry of Health (MoH) stated that it is following all the latest updates regarding the new virus with the World Health Organisation (WHO). It confirmed that the virus is not a concern for public health at the moment as the detected cases globally continue to be very low.
It reiterated that the current situation does not require a travel ban to any country in the world, nor screenings at different ports, or restrictions on trade. The MoH praised the cooperation and coordination among all the health authorities in the country to follow up the health situation and safeguard public health.

Thursday, July 18, 2013

#MERS #Coronavirus Saudi Arabia Case List

The Asir cluster [the case numbering is this blogs numbers only]:


#35—66(M)—Asir Province—Critical but Stable cond.
#36—26(M)—Asir Province—no adm—contact of #35—mild case
#37—42(F)—Asir Province—no adm—healthcare worker-mild case

#MERS #Coronavirus Saudi Arabia: 2 New Cases

17 July 2013
Within the framework of the epidemiological surveillance of the novel Coronavirus (MERS-CoV), the Ministry of Health (MOH) has announced that two confirmed cases of this virus have been recorded. The first case is for a 26-old-year Saudi male in Asir, who was in contact with one of the cases previously announced to be infected with the virus. The second case is for a 42-year-old female resident working at the health sector in Asir. Both cases have mild symptoms, so it was not recommended to be hospitalized.

It is worth mentioning that, the MOH has tested 1460 samples from the beginning of the previous month (Sha‘ban), given that, all of such samples have been proved negative, May Allah be praised, except the cases that have been published.

http://www.moh.gov.sa/en/HealthAwareness/Corona/PressReleases/Pages/News-2013-07-17-001.aspx

China: H7N9 patient gives birth to healthy baby

NANJING, July 18 (Xinhua) -- The world's first pregnant woman infected with H7N9 bird flu gave birth to a heathy girl on Wednesday afternoon in a hospital in Zhenjiang City, east China's Jiangsu Province.

The 25 year old surnamed Qiu was five months pregnant when she was diagnosed with H7N9 on April 8. She was admitted to the intensive care unit in Zhenjiang No. 1 People's Hospital. She came around on April 21 and recovered in May.

Qiu received a Cesarean section on Wednesday afternoon and gave birth to a baby girl weighing 3.3 kg, according to doctors with hospital. Gu Shaoqing, head of the paediatric department, said Qiu's expected date of childbirth had been set for July 26. However, doctors monitored an acceleration in the fetal heart beat, and decided to carry out the operation on Wednesday.
They said Qiu's cardiopulmonary function still needs time for recovery. The hospital will continue to monitor the health of the mother and baby.

A total of 132 H7N9 avian flu cases have been reported on the Chinese mainland, including 43 that have ended in death, since the virus was first discovered in March, according to updates released by the National Health and Family Planning Commission on July 10. The spread of the disease has been brought under control, as there was only one new case reported in east China's Jiangsu Province last month and the patient has recovered, according to the commission's updates.

 http://news.xinhuanet.com/english/bilingual/2013-07/18/c_132552883.htm 

Wednesday, July 17, 2013

#MERS Virus Not Yet a Global Emergency, WHO Panel Says

hat-tip Helen Branswell
on 17 July 2013
Excerpt:

A special panel established by the World Health Organization (WHO) decided today that the novel coronavirus that has been infecting people in the Middle East is "very concerning," but does not yet constitute a "public health emergency of international concern."

-snip-

Under a global agreement known as the International Health Regulations, the panel's declaration of an emergency would give WHO the power to issue recommendations on addressing MERS.
After convening by telephone for 4 hours this afternoon, the panel unanimously decided that the conditions for a public health emergency of international concern had not been met—so far.

The committee decided that "this was not the time to go ahead with such a declaration but to monitor the situation very closely," said Keiji Fukuda, WHO's assistant director-general for health security and environment, at a press conference in Geneva, Switzerland. In part, the decision reflected the negative effects an emergency declaration could also have, he noted. "You want to make these declarations when they are proportionate to the event."

The panel made the right call, says Mike Osterholm, director at the Center for Infectious Disease Research and Policy at the University of Minnesota, Twin Cities. But he worries that some people could take the decision to mean that there is nothing to worry about. "We have this unfortunate nomenclature that has been given to us," he tells ScienceInsider. "And it is either a yes or a no." 

continued:  http://news.sciencemag.org/scienceinsider/2013/07/mers-virus-not-yet-a-global-emer.html

ProMED Comments on WHO Emergency Committee assessment

WHO Statement (excerpt):

Based on these views and the currently available information, the Director-General accepted the Committee's assessment that the current MERS-CoV situation is serious and of great concern, but does not constitute a PHEIC at this time.
ProMED
excerpt: (comments after WHO statement)
[The above is the official statement of the WHO IHR Emergency Committee that was convened to assess the global risks of MERS-CoV. At present, the Committee felt that "with the information now available, and using a risk-assessment approach, the conditions for a Public Health Emergency of International Concern (PHEIC) have not at present been met." The term Public Health Emergency of International Concern (PHEIC) is defined in the IHR (2005) as "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response." This definition implies a situation that: is serious, sudden, unusual or unexpected; carries implications for public health beyond the affected State's national border; and may require immediate international action. (see http://www.who.int/ihr/procedures/pheic/en/ for a description of PHEIC procedures).

For the HealthMap/ProMED map of the Middle East Region where all cases to date have a direct or indirect link, see http://healthmap.org/r/1HAJ. - Mod.MPP]

http://www.promedmail.org/direct.php?id=20130717.1830415

Frequently Asked Questions on Middle East Respiratory Syndrome – coronavirus (MERS-CoV)

[This will be updated on the right side-bar of this blog under MERS-CoV]
Updated
July 17, 2013

What is coronavirus?

Coronaviruses are a large family of viruses that cause illness in humans and animals. In people, coronaviruses can cause illnesses ranging in severity from the common cold to Severe Acute Respiratory Syndrome (SARS).
The novel coronavirus, first detected in April 2012, is a new virus that has not been seen in humans before. In most cases, it has caused severe disease. Death has occurred in about half of cases.
This new coronavirus is now known as Middle East Respiratory Syndrome – coronavirus (MERS-CoV). It was named by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses in May 2013.

Where are MERS-CoV infections occurring?

Nine countries have now reported cases of human infection with MERS-CoV. Cases have been reported in France, Germany, Italy Jordan, Qatar, Saudi Arabia, Tunisia and the United Arab Emirates. All cases have had some connection (whether direct or indirect) with the Middle East. In France, Italy, Tunisia and the United Kingdom, limited local transmission has occurred in people who had not been to the Middle East but who had been in close contact with laboratory-confirmed or probable cases.

How widespread is MERS-CoV?

How widespread this virus may be is still unknown. WHO encourages Member States to continue to closely monitor for severe acute respiratory infections (SARI) and to carefully review any unusual patterns of SARI or pneumonia. WHO will continue to share information as it becomes available.

What are the symptoms of MERS-CoV?

Common symptoms are acute, serious respiratory illness with fever, cough, shortness of breath and breathing difficulties. Most patients have had pneumonia. Many have also had gastrointestinal symptoms, including diarrhoea. Some patients have had kidney failure. About half of people infected with MERS-CoV have died. In people with immune deficiencies, the disease may have an atypical presentation. It is important to note that the current understanding of illness caused by this infection is based on a limited number of cases and may change as we learn more about the virus.

How do people become infected with this virus?

We do not yet know how people become infected with this virus. Investigations are underway to determine the source of the virus, the types of exposure that lead to infection, the mode of transmission, and the clinical pattern and course of disease.

Can the virus be transmitted from person to person?

Yes. We have now seen multiple clusters of cases in which human-to-human transmission has occurred. These clusters have been observed in health-care facilities, among family members and between co-workers. However, the mechanism by which transmission occurred in all of these cases, whether respiratory (e.g. coughing, sneezing) or direct physical contact with the patient or contamination of the environment by the patient, is unknown. Thus far, no sustained community transmission has been observed.

Is there a vaccine or treatment for MERS-CoV?

No. No vaccine is currently available. Treatment is largely supportive and should be based on the patient’s clinical condition.

How can people protect themselves from getting MERS-CoV?

It is not possible to give specific advice on prevention, as neither the source of the virus nor the mode of transmission is yet certain. It is always prudent to avoid close contact, when possible, with anyone who shows symptoms of respiratory illness and to maintain good hand hygiene. Other effective general measures include avoiding eating uncooked or undercooked meats, unwashed or unpeeled fruits or vegetables, and consuming drinks made without clean water. If you become sick while travelling, you should avoid close contact with other people while you have symptoms and use good respiratory hygiene. If you have respiratory symptoms, such as coughing or sneezing, you should cough or sneeze into a sleeve or flexed elbow, or tissue, and throw used tissues into a closed bin immediately after use.
The chances of contracting the virus are small. However, people who meet the following criteria should see a health-care worker as soon as possible: people who have travelled to the Middle East who develop breathing difficulties that are not explained by any other illness or virus; ill people who are immunocompromised and have recently travelled to the Middle East.

How many people have been infected by MERS-CoV?

Are health workers at risk from MERS-CoV?

Yes. Transmission has occurred in health-care facilities, including spread from patients to health-care providers. WHO recommends that health-care workers consistently apply appropriate infection prevention and control measures.

How is WHO responding to the emergence of MERS-CoV?

Since the emergence of this virus, WHO has been working under the International Health Regulations to gather scientific evidence to better understand this virus and provide information to Member States. For this purpose, WHO convened the first international meeting on MERS-CoV in Cairo in January 2013.
On 19-22 June, WHO convened a second meeting in Cairo to discuss advances in scientific research and the international response to MERS-CoV. On 5 July, WHO announced it would convene an Emergency Committee under the International Health Regulations (2005). This Committee will advise the Director-General as to whether this event constitutes a Public Health Emergency of International Concern (PHEIC). The Committee may also offer advice to the Director-General on public health measures that should be taken.
WHO is also working with affected countries and international partners to coordinate the global health response, including the provision of updated information on the situation, guidance to health authorities and technical health agencies on interim surveillance recommendations, laboratory testing of cases, infection control, and clinical management.

What is WHO recommending that countries do?

WHO encourages all Member States to enhance their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns of SARI or pneumonia cases. WHO urges Member States to notify or verify to WHO any probable or confirmed case of infection with MERS-CoV.

Has WHO recommended any travel or trade restrictions related to this new virus?

No. WHO does not recommend any travel or trade restrictions with respect to MERS-CoV. WHO will continue to review all recommendations as more information becomes available.

http://www.who.int/csr/disease/coronavirus_infections/faq/en/index.html 

WHO Statement on the Second Meeting of the IHR Emergency Committee concerning MERS-CoV

WHO Statement
17 July 2013
The second meeting of the Emergency Committee convened by the Director-General under the International Health Regulations (2005) [IHR (2005)] was held by teleconference on Wednesday, 17 July 2013, from 12:00 to 16:04 Geneva time (CET).
In addition to Members of the Emergency Committee, an expert advisor to the Committee1 participated in the meeting. During the informational session of the meeting, several affected States Parties were also on the teleconference. The States Parties on the teleconference were: France, Germany, Italy, Jordan, Kingdom of Saudi Arabia, Qatar, Tunisia, and the United Kingdom.
The Committee reviewed and deliberated on information on a range of aspects of MERS-CoV, which was prepared or coordinated by the Secretariat and States in response to questions presented by Members during the first meeting.
It is the unanimous decision of the Committee that, with the information now available, and using a risk-assessment approach, the conditions for a Public Health Emergency of International Concern (PHEIC) have not at present been met.
While not considering the events currently to constitute a PHEIC, Members of the Committee did offer technical advice for consideration by WHO and Member States on a broad range of issues, including the following:
  • Improvements in surveillance, lab capacity, contact tracing and serological investigation
  • Infection prevention and control and clinical management
  • Travel-related guidance
  • Risk communications
  • Research studies (epidemiological, clinical and animal)
  • Improved data collection and the need to ensure full and timely reporting of all confirmed and probable cases of MERS-CoV to WHO in accordance with the IHR (2005).
The WHO Secretariat will provide regular updates to the Members and will reconvene the Committee, in September, on a date to be determined. However, serious new developments may require an urgent re-convening of the Committee before then.
Based on these views and the currently available information, the Director-General accepted the Committee’s assessment that the current MERS-CoV situation is serious and of great concern, but does not constitute a PHEIC at this time.
The Director-General expressed her gratitude to the Committee on its wide range of advice on health actions for countries to implement, and advice on follow-up work by WHO.

1 Please note that the listing of Emergency Committee Members on the WHO website has been updated to include the adviser to the Committee.

For more information contact

Fadéla Chaib
Communications Officer
Department of Communications
WHO, Geneva
Telephone: +41 22 7913228
Mobile: +41 79 475 5556
E-mail: chaibf@who.int

Mr Tarik Jasarevic
Communications Officer
Department of Communications
WHO, Geneva
Telephone: +41 22 791 50 99
Mobile: +41 79 367 62 14
E-mail: jasarevict@who.int

Mr Glenn Thomas
Communications Officer
Department of Communications
WHO, Geneva
Telephone: +41 22 791 3983
Mobile: +41 79 509 0677
E-mail: thomasg@who.int


http://www.who.int/mediacentre/news/statements/2013/mers_cov_20130717/en/index.html 

India: Govt wakes up to MERS threat, asks states to keep vigil

[An earlier post of July 15th, speaks of the Gov's lax position, located here]

July 17, 2013
With the spread of the SARS-like Middle East coronavirus in many countries, the Centre has asked all states for increasing surveillance and keeping a close vigil on those travelling to Gulf nations.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) can cause fever, coughing and pneumonia. It is related to Severe Acute Respiratory Syndrome (SARS) and its symptoms are also similar to H1N1 or Swine flu.

The virus has already killed more than 45 people across the world and its impact is more visible in the middle east countries. The largest number of deaths have taken place in Saudi Arabia. It has sparked fears of a SARS-like outbreak in Asia which left 800 people dead in 2003. So far, no case of MERS has been reported in India.
In a circular issued to all states, the Health Ministry has said that the virus has become a global threat and patients with travel history to the Middle East, China and Taiwan who show signs of respiratory discomfort should be reported and kept under surveillance. 

The Ministry has also asked the state health officials under the Integrated Disease Surveillance Programme (IDSP) to keep a vigil.


Sources in the Ministry said a total of 81 cases have been reported cross the world with WHO.
Doctors said the symptoms for the virus are similar to that in swine flu where a patient suffers acute respiratory problems. Doctors say the infection leads to pneumonia which can prove fatal.

The Health Ministry advisory has asked the states to inform the hospitals in each district to collect samples of patients with such symptoms where H1N1 is found negative and said such samples should be sent to National Institute of Virology in Pune and the National Centre for Disease Control in Delhi. 

WHO's International Health Regulation Emergency Committee on MERS is meeting in Geneva today to work out a strategy to tackle the virus.

Pakistan: Immediate Medical Tests on Every Pilgrim Returning from Hajj & Umrah #MERS #Coronavirus

KARACHI - Middle East Corona Virus is feared to have been transmitted to Pakistan from Saudi Arabia through pilgrims returning from Hajj and Umrah.
Media reports said that the National Institute of Health (NIH) had informed all provincial health departments in this regard. NIH had also directed provincial departments to monitor every person coming from Saudi Arabia, Jordan and other countries.

Talking to reporters, an official of NIH had said that samples of patients suffering from respiratory infection should be collected immediately and measures for their treatment should be taken as soon as possible. He said that if evidence of the virus was found in any person, then his treatment should be started on emergency basis to prevent the spread of this virus in the country.
“Immediate medical tests should be conducted for the pilgrims returning from Hajj and Umrah,” he concluded.

http://www.pakistantoday.com.pk/2013/07/16/city/karachi/middle-east-corona-virus-being-transmitted-from-saudi/

WHO Emergency Committee decides today if #MERS #Coronavirus is an "Emergency"

[The information on the IHR Emergency Committee concerning Middle East respiratory syndrome coronavirus (MERS-CoV) can be found here]  

Is MERS an emergency?  Language of IHR boxes WHO into a messaging dilemma

By Helen Branswell, The Canadian Press  
July 16, 2013

TORONTO - Would you choose the word "emergency" to describe a disease that has sickened 82 people in eight countries over the last 16 months? Would your thinking change if you knew it had killed 45 of those people? What about if you knew the virus that caused the disease is related to the one that caused SARS?

Despite the high death rate and SARS connection, it's hard to imagine many lay people would currently see the slow-but-steady MERS coronavirus outbreak as an emergency. And yet a panel of international experts — known as the Emergency Committee — is being asked whether they think the disease event meets that definition when they gather by teleconference Wednesday to assess the threat posed by the Middle Eastern respiratory syndrome virus.

The experts, pulled together by the World Health Organization under powers given it by the International Health Regulations (the IHR), are expected to advise WHO Director General Dr. Margaret Chan on Wednesday whether she should declare MERS a "public health emergency of international concern" or PHEIC, in the jargon of the WHO. Chan doesn't have to take the advice, but it's hard to see why she would reject the guidance after asking for it.

-snip-
Continued:  http://www.canada.com/health/MERS+emergency+Language+boxes+into+messaging+dilemma/8667775/story.html

Tuesday, July 16, 2013

Vietnam: No Cases Reported of #H7N9 or #MERS #Coronavirus

July 15, 2013
No cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and avian influenza H7N9 have been reported so far in Vietnam, a health official has said.

Deputy Head of the Preventive Medicine Department under the Health Ministry Tran Dac Phu made the affirmation at a meeting in Hanoi on July 15.

He noted however, that there are risks that MERS-CoV may enter Vietnam in the context of expanding trade and tourism ties with foreign countries, including those where the new deadly coronavirus strain is raging.

There currently no vaccine or treatment for MERS-CoV, the health official said, adding that some infected cases show no symptoms, hindering the control of the disease.

Continued:  http://en.vietnamplus.vn/Home/No-MERSCoV-H7N9-cases-reported-so-far-in-Vietnam/20137/36747.vnplus

Cambodia bird flu outbreak continues with 14th case #H5N1

[It appears the 3 year old from Cambodia, that was recently diagnosed with H5N1 bird flu, is from Kampong Trabek district.  A map of Prey Veng Province is below the article.]


July 16, 2013
Excerpt:
Cambodia's outbreak of H5N1 avian influenza continues apace as the summer wears on, with a 3-year-old boy becoming the 14th victim this year and the 35th case confirmed in the Southeast Asian nation since records began to be kept.

The Cambodian Ministry of Health has deployed a rapid response team to Prey Veng's Kampong Trabek district to perform "contact tracing" or mass testingof everyone who came into contact with the recently diagnosed 3-year-old boy, including both family and neighbors, according to the World Health Organization (WHO).

continued:  http://www.globalpost.com/dispatch/news/regions/asia-pacific/cambodia/130716/cambodia-bird-flu-outbreak-continues-14th-case


H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance

Press Release
July 16, 2013
Contact: Jim Sliwa

Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains.

The authors of a study published in mBio®, the online open-access journal of the American Society for Microbiology, characterized viruses taken from the first person known to be stricken with H7N9 influenza and found that 35% of those viruses are resistant to oseltamivir (commercially known as Tamiflu) and zanamivir (Relenza), front line drugs used for treating H7N9 infections. However, lab testing of the viruses, which detects the activity of a viral enzyme, fails to detect that these strains are resistant, so monitoring for the development of resistance using this technique would prove futile.

"If H7N9 does acquire human-to-human transmissibility, what do we have to treat it with until we have a vaccine? Oseltamivir. We would be in big trouble," says corresponding author Robert Webster of St. Jude Children's Research Hospital in Memphis, Tennessee. Resistant strains of H7N9 can flourish in patients treated with oseltamivir or zanamivir, he says, inadvertently leading to the spread of resistant infections.

In the mBio study, the authors tested antiviral susceptibility of an H7N9 strain isolated from the first confirmed human case of avian H7N9 influenza using a method that tests the activity of the neuraminidase enzyme. The reassuring results were, unfortunately, misleading: the enzyme-based test indicated that the flu strain was susceptible to NA inhibiting antiviral drugs, but it is not. 

A closer look at the viral isolate revealed it is actually made up of two distinct types of H7N9 viruses. Roughly 35% of the viruses carry the R292K mutation, making them resistant to NA inhibitors, and 65% are sensitive to these same drugs. The enzyme-based testing gave misleading results, says Webster, because the functioning wild-type enzymes masked the presence of the non-functioning mutant enzymes. 

Using NA inhibitors to treat a patient infected with a resistant strain of H7N9 only encourages the virus to proliferate and can lead to enhanced spread of the resistant strain. The authors write that these results prove that it is crucial to use a gene-based surveillance technique that can detect these resistant influenza strains in a mixed infection.

H7N9 first emerged in China in early 2013, in some cases infecting individuals who had been in contact with poultry or with places where poultry are housed. The virus has since been detected in poultry at live markets near where human infections have been reported. After the closure of many live poultry markets in China and with the start of the warm season, which is not conducive to influenza spread, the infection rate appears to have slowed. As of July 12, the number of infections stands at 132 and the number of deaths at 43.

A recent study found that antiviral treatment failed in two patients infected with a strain of H7N9 influenza that carries a mutation called R292K, and that these patients had a poor clinical outcome. The mutation causes a change in the neuraminidase gene and makes the virus resistant to neuraminidase (NA) inhibitors, including Tamiflu and Relenza. NA inhibitors have been the front line therapeutic option for treating H7N9 influenza because the virus is already resistant to M2 ion channel blockers Amantadine (Symmetrel) and its methyl derivative Rimantadine (Flumadine). Considering the severity of H7N9 flu infection and the fact that so few options exist for treatment, it is important to continue to evaluate the sensitivity of clinical isolates to NA inhibitors and to monitor for the emergence of resistant variants. 

If the recent history of H5N1 influenza is a guide, says Webster, then H7N9 could rapidly evolve the ability to spread from person to person. If it does, and if the virus reemerges in the fall, the situation with H7N9 could become quite serious. In the event of a widespread outbreak, Tamiflu and Relenza will work alright as treatments, but the development of the R292K mutation puts those options in jeopardy, says Webster. 

But the news isn't all bad. Webster also points out that antiviral resistance is something of a burden for influenza viruses, and that fitter wild-type H7N9 strains may eventually win out over resistant strains. In the absence of a drug like Tamiflu, Webster says, it seems unlikely that these resistant viruses would acquire epidemic characteristics. 

Regardless of the specific evolutionary steps H7N9 will take, influenza is an ongoing threat - and the lack of suitable drugs is a grave cause for concern.
"The great need at the moment are additional drugs aimed at additional sites in the influenza genome. There are some [drugs] in the pipeline, but they are still under testing at the moment," says Webster. "We'd better get some vaccine seed stocks up and ready. The antiviral option for controlling H7N9 isn't too good."

http://www.eurekalert.org/pub_releases/2013-07/asfm-his071213.php

Monday, July 15, 2013

MERS coronavirus likely to spread as UAE-Saudi travel increases

Jennifer Bell & Emily Cleland
July 15, 2013
Excerpt [editing is mine]:

The Mers virus is more likely to spread as travel increases between the UAE and Saudi Arabia, where most cases of the disease have been found, doctors have warned.
-snip-
The 82nd victim of the virus is in intensive care in an Abu Dhabi hospital after the condition was diagnosed at the weekend. The Emirati, 82, was already being treated for multiple myeloma, a cancer of the bone marrow. Patients with existing conditions are particularly susceptible to Mers.
-snip-
Dr Keiji Fukuda, assistant director general for health security at the World Health Organisation, says there are three possible scenarios for the future development of the disease: it will die out, or stay at its current level, or the virus will mutate and infections will increase.

Dr Fukuda said this month he was not advising that the Haj be cancelled. Muslim-majority nations, he said, were aware of the threat of the virus and would be vigilant as pilgrims returned.

Nevertheless, Dr Mansour Al Zarouni, a consultant molecular microbiologist at SRL Diagnostics in Dubai Healthcare City, is concerned at the possible threat to the Haj from Mers. "When all these hundreds of thousands of people are coming, from North Africa to South-east Asia, for Haj, these people will be incubating the virus while in Saudi Arabia and taking it back to their home countries," he said. "Until the Haj season, the issue is mostly a GCC issue but, after Haj, then there's very much a possibility it shall become more of a global issue."

He is also concerned by travel between Saudi Arabia and the UAE before then. "Due to the fact that many Saudis are going to be pouring into the GCC, mainly the UAE, during the summer … the assumption is that they will be bringing these viruses along and, due to the heat of summer, these people will mostly stay indoors, be it the shopping malls or hotels. The likelihood of infecting other people will be higher," he said.

http://www.thenational.ae/news/uae-news/health/mers-coronavirus-likely-to-spread-as-uae-saudi-travel-increases

Coronavirus : des restrictions au pèlerinage de La Mecque

Pauline Fréour - le 15/07/2013

L'Arabie saoudite déconseille aux personnes âgées ou souffrant de maladies chroniques d'effectuer le pèlerinage à La Mecque en raison de l'épidémie de coronavirus qui a fait 38 morts dans le royaume.
La première restriction de voyage liée au nouveau coronavirus vient d'être publiée. Samedi, les autorités saoudiennes ont recommandé aux pèlerins musulmans ayant une santé fragile de reporter leur venue à La Mecque. Cette mise en garde est valable à la fois pour le grand pèlerinage (hajj), qui aura lieu cette année en octobre, et le petit pèlerinage, appelé oumra, souvent effectué pendant le mois du Ramadan, qui a débuté le 10 juillet cette année.
L'avis publié par le ministère de la Santé sur son site concerne les personnes âgées, souffrant d'une maladie chronique ou aux défenses immunitaires affaiblies, ainsi que les femmes enceintes et les enfants. Aucune limite d'âge n'a cependant été précisée et le ministère n'explique pas clairement si ces recommandations impliqueront une non-délivrance de visa aux pèlerins concernés par ces restrictions sanitaires.

45 victimes dans le monde

Le nouveau coronavirus, dit du Syndrome respiratoire du Moyen-Orient (MERS), est apparu en Arabie saoudite en 2012. Depuis, il a causé 45 morts dans le monde pour 81 cas répertoriés. Le royaume saoudien comptabilise à lui seul 38 décès.
Les autorités sanitaires internationales sont mobilisées pour tenter d'en savoir plus sur ce nouveau virus qui a également fait un mort en France fin mai. Les informations restent encore clairsemées mais il semblerait que le virus puisse être transmis d'homme à homme en cas de contact prolongé. C'est pourquoi la perspective du rassemblement de millions de pèlerins musulmans cet été et à l'automne suscite l'inquiétude.
L'Organisation mondiale de la santé (OMS), dont la dernière réunion d'urgence sur le sujet s'est tenue mardi dernier, ne recommande pour l'instant aucune restriction de voyage mais demande aux autorités sanitaires de suivre avec la plus grande attention tout cas de personne présentant les symptômes propres au MERS: toux, essoufflement, gêne respiratoire, fièvre supérieure à 38°C, voire insuffisance rénale.

Government’s lax stand could allow MERS Coronavirus into Mumbai

Author :
July 15, 2013
Excerpt:
Our inept government is again in the dock for not being up to speed with recent developments. With Saudi Arabia and other Gulf countries witnessing an outbreak of a new SARS-like virus called MERS (Middle East Respiratory Syndrome) Coronavirus, India hasn’t taken any precautions to screen passengers arriving from the aforementioned countries.

With more cases being reported every single day, the WHO has declared the virus ‘a threat to the entire world’. With little knowledge about the virus in India and no healthcare precautions to deal with yet, airline crew are a worried lot. The crew are also angry at their airlines; reports suggest while many Air India air-hostesses traveling to the Gulf have taken ill the airline hasn’t taken any steps to conduct thorough medical checks on them.
-snip-
Over a thousand passengers arrive in Mumbai from the Gulf States every day and Air India alone flies 600 passengers from Jeddah and Riyadh every day. ‘Most of the poor subsidised pilgrims fly Air India as it is the official carrier,’ said an airline official who did not want to be named. ‘Since they are travelling on a subsidy their camps are not very hygienic. Air India crew, thus, are at the highest risk. But neither the airline nor the government has taken any steps to address this issue.’

‘The crew are advised to maintain hygiene and cover their mouths and noses while ensuring that they consume only clean water and cooked meat,’ said an AICCA office bearer. ‘What kind of advisory is this? It strangely does not even talk about the precautions to be adopted on board the aircraft, where crew members end up mingling with passengers who might have contracted the virus.’

Further, airlines have asked crew members to ‘keep an eye out for passengers who might be suffering from MERS.’  ‘How we are expected to do this, nobody knows,’ said the AICCA official. ‘What the airlines should do instead is to screen passengers thoroughly before they board aircrafts.’ ‘There is a scare of the virus,’ said a Saudi Airlines official. ‘We have a lot of bookings to Mumbai. But there is no active screening happening yet. The World Health Organisation sounded a general alert. But there has been no official word from the WHO on the need for ‘active’ surveillance.’
-snip-
While the virus doesn’t seem to pose any particular threat to the public as of now, healthcare professionals are watching all the developments closely. Most European and American healthcare facilities have the facilities to perform a test for the new coronavirus but the problem is figuring out who to test. An even bigger problem is the virus spreads in nations with limited healthcare facilities and huge populations like India, China or even South Africa. That could really trigger a pandemic of epic proportions and ramifications.

http://health.india.com/news/governments-lax-stand-could-allow-mers-coronavirus-into-mumbai/

Sunday, July 14, 2013

Viroblock SA Masks for #Coronavirus Press Release & Retail Information

Geneva, Switzerland, June 26, 2013 -- Viroblock SA, a Swiss start-up, today presented new data at ICPIC 2013 in Geneva, showing that their face-mask containing proprietary novel cholesterol depletion technology traps and kills over 99.9995% of H1N1 flu viruses (swine flu), 99.999% of H5N1 flu viruses (avian flu) and 99.997% human corona viruses on pass through air. Aimed at helping protect people from these respiratory pathogens, the mask is up to one hundred times more effective than a similar mask without Viroblock technology. The company will now start direct sales in Switzerland and is looking for distributors in other countries.
“Aerobiology tests for face-masks simulate real life situations, in which the user is exposed to viruses coming in. The mask helps prevent transmission from and to the person wearing the mask.” commented Dr Thierry Pelet, CSO at Viroblock. “The stringent testing demonstrates the efficacy and speed at which the cholesterol depletion technology works”.
Aerobiology tests, carried out in high security laboratories, create a mist of viruses on the outside of the mask, a pump is used to draw air and viruses through the mask, and finally testing for live virus occurs on the inside of the mask.
“We believe that our protective face-mask can help protect healthcare, agriculture and security workers effectively, with added advantages of comfort of wear and easy identification,” said Dr Jamie Paterson, CEO of Viroblock.
-snip-
For further information, please contact:
Danièle Castle
Genevensis Healthcare Communications
T: +4179 202 66 67
Mail: info@genevensis.com

Our retailers

Here are our retailers locations, please feel free to contact us:

VIROBLOCK SA 

Chemin des Aulx 18  

1228 Plan-les-Ouates

Switzerland
Phone: +41 22 884 83 46
Fax: +41 22 794 66 65
Email: info@viroblock.com
Website: http://www.viroblock.com

VALMY SAS

La demi-lieue - Rue Benjamin Franklin
42300 Mably
France
Phone: +33 477 23 11 21
Fax: +33 477 72 54 57
Email: info@valmy.eu
Website: http://www.valmy.eu

http://www.viroblock.com/content/30-viroblock-press-release 

Saudi Arabia: #MERS New face mask can check #coronavirus

[Specific information to order this mask, is located in the following link:  http://pandemicinformationnews.blogspot.com/2013/07/viroblock-sa-masks-for-coronavirus.html ]

Sunday 14 July 2013
Last Update 14 July 2013 8:04 pm
A Swiss company has introduced a new face mask to combat the risk of infection in mass gatherings amid growing anxiety about the status of the new coronavirus during the forthcoming Haj season.
Latest reports indicate that as many as 66 people have been infected with the virus in the Kingdom, while 38 have died.
As a large number of Muslims are expected to visit Makkah and Madinah during Ramadan and the upcoming Haj season in October, the new technology can be used to assist in reducing the risk and incidence of air-borne infection.
Launching the face mask at a conference in Geneva, workers of Viroblock SA, its makers, demonstrated its qualities. It uses technology that traps and kills over 99.9995 percent of air-borne H1N1 flu viruses (swine flu), 99.999 percent of H5N1 flu viruses (avian flu) and 99.997 percent of human coronaviruses.
Developed with the aim of protecting people from respiratory pathogens, the mask contains an effective technology that significantly reduces the threat of air-borne transmitted diseases. “Aerobiology tests for face masks simulate real-life situations, in which the user is exposed to viruses coming in. The mask helps prevent transmission from and to the person wearing the mask,” explained Thierry Pelet of Viroblock. “The stringent testing demonstrates the efficacy and speed at which the cholesterol depletion technology works.”
Aerobiology tests, carried out in high-security laboratories, create a mist of viruses on the outside of the mask. A pump is then used to draw air and viruses through the mask, and finally, testing for the live virus occurs on the inside of the mask.
“We believe that our protective face mask can help protect agriculture and security workers effectively, with the added advantages of comfort of wear and easy identification,” said Jamie Paterson, CEO of Viroblock.

WHO: Middle East respiratory syndrome coronavirus (MERS-CoV) - update 13 July 2013

13/07/2013


The Ministry of Health (MoH) in the United Arab Emirates (UAE) has notified WHO of a laboratory-confirmed case of infection with Middle East respiratory syndrome coronavirus (MERS-CoV) in the country.

The patient is an 82-year-old man with underlying medical conditions and is currently in critical condition.

Globally, from September 2012 to date, WHO has been informed of a total of 82 laboratory-confirmed cases of infection with MERS-CoV, including 45 deaths.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to maintain vigilance. Recent travelers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations.

Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that MERS-CoV infection should be considered even with atypical signs and symptoms, such as diarrhea, in patients who are immunocompromised.

Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO has convened an Emergency Committee under the International Health Regulations (IHR) on a precautionary basis in order to be prepared for a change in the situation. The Emergency Committee, which comprises international experts from all WHO Regions, will provide expert technical advice to the WHO Director-General in accordance to the IHR (2005). The first meeting of the Committee took place on 9 July 2013 and a further meeting is scheduled for next week.

http://www.who.int/csr/don/don_updates/en/index.html